MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner
Kana Miyamoto(Kumamoto University), Takeshi Miyamoto(Kumamoto Health Science University), Toshio Suda(Chinese Academy of Sciences), Kazuhiro Chiba(Akita Prefectural University), Hiroko Hoshi(Japanese Red Cross Narita Hospital), Koh‐Hei Sonoda(Kyushu University), Ken Ninomiya(Kawasaki Hospital), Yoshiteru Miyauchi(Mitsubishi Chemical (Japan)), Hiroya Miyamoto(Keio University), Yoshiaki Toyama(Keio University), Ryotaro Iwasaki(Keio University), Yuiko Sato(Keio University), Shigeyuki Yoshida(Keio University), Kensuke Egashira(Kyushu University), Hideo Morioka
Cited by 95
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium
|Circulation Research|1999|700